Breaking News

Formex Names Scientific Advisor

August 14, 2014

McCarty brings 30 years of drug development experience

John McCarty has been named scientific advisor at Formex LLC, and a science advisory board member. Mr. McCarty has more than 30 years of experience in drug product development in the pharmaceutical and biotechnology industries, with expertise in the development of all major dosage forms, and is an inventor on 17 patents. 
Mr. McCarty previously held several senior management positions in R&D at Key Pharmaceuticals, Schering–Plough, and Pharmavene (acquired by Shire) and also served as vice president of formulation development at Azo Pharma.
"John brings a wealth of knowledge and expertise in formulation development, operations, and manufacturing for both clinical and commercial products to Formex.  We are extremely pleased to work with John as our Senior Consultant and Member of our Scientific Advisory Board," said Dr. J. Blair West, chief scientific officer of Formex. "John is well prepared to contribute to Formex as we continue to grow and expand in our capabilities and market presence."

blog comments powered by Disqus
  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.